Immune Response BioPharma Inc - Product Pipeline Review

Global Markets Direct’s, ‘Immune Response BioPharma Inc - Product Pipeline Review - 2016’, provides an overview of the Immune Response BioPharma Inc’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Immune Response BioPharma Inc, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Immune Response BioPharma Inc

The report provides overview of Immune Response BioPharma Inc including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Immune Response BioPharma Inc’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Immune Response BioPharma Inc’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Immune Response BioPharma Inc’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Immune Response BioPharma Inc

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Immune Response BioPharma Inc’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Introduction 5

Global Markets Direct Report Coverage 5

Immune Response ...

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Introduction 5

Global Markets Direct Report Coverage 5

Immune Response BioPharma Inc Snapshot 6

Immune Response BioPharma Inc Overview 6

Key Facts 6

Immune Response BioPharma Inc - Research and Development Overview 7

Key Therapeutic Areas 7

Immune Response BioPharma Inc - Pipeline Review 9

Pipeline Products by Stage of Development 9

Pipeline Products - Monotherapy 10

Immune Response BioPharma Inc - Pipeline Products Glance 11

Immune Response BioPharma Inc - Late Stage Pipeline Products 11

Pre-Registration Products/Combination Treatment Modalities 11

Immune Response BioPharma Inc - Clinical Stage Pipeline Products 12

Phase II Products/Combination Treatment Modalities 12

Phase I Products/Combination Treatment Modalities 13

Immune Response BioPharma Inc - Early Stage Pipeline Products 14

Preclinical Products/Combination Treatment Modalities 14

Immune Response BioPharma Inc - Drug Profiles 15

IR-007 - Drug Profile 15

Product Description 15

Mechanism Of Action 15

R&D Progress 15

IR-1000 - Drug Profile 16

Product Description 16

Mechanism Of Action 16

R&D Progress 16

IR-1002 - Drug Profile 17

Product Description 17

Mechanism Of Action 17

R&D Progress 17

IR-103 - Drug Profile 18

Product Description 18

Mechanism Of Action 18

R&D Progress 18

IR-2020 - Drug Profile 20

Product Description 20

Mechanism Of Action 20

R&D Progress 20

IR-222 - Drug Profile 21

Product Description 21

Mechanism Of Action 21

R&D Progress 21

IR-444 - Drug Profile 22

Product Description 22

Mechanism Of Action 22

R&D Progress 22

IR-502 - Drug Profile 23

Product Description 23

Mechanism Of Action 23

R&D Progress 23

IR-555 - Drug Profile 24

Product Description 24

Mechanism Of Action 24

R&D Progress 24

IR-777 - Drug Profile 25

Product Description 25

Mechanism Of Action 25

R&D Progress 25

IR-888 - Drug Profile 26

Product Description 26

Mechanism Of Action 26

R&D Progress 26

IR-902 - Drug Profile 27

Product Description 27

Mechanism Of Action 27

R&D Progress 27

IR-999 - Drug Profile 29

Product Description 29

Mechanism Of Action 29

R&D Progress 29

IRE-101 - Drug Profile 30

Product Description 30

Mechanism Of Action 30

R&D Progress 30

IRR-102 - Drug Profile 31

Product Description 31

Mechanism Of Action 31

R&D Progress 31

IRS-103 - Drug Profile 32

Product Description 32

Mechanism Of Action 32

R&D Progress 32

Remune - Drug Profile 33

Product Description 33

Mechanism Of Action 33

R&D Progress 33

Immune Response BioPharma Inc - Pipeline Analysis 36

Immune Response BioPharma Inc - Pipeline Products by Target 36

Immune Response BioPharma Inc - Pipeline Products by Route of Administration 37

Immune Response BioPharma Inc - Pipeline Products by Molecule Type 38

Immune Response BioPharma Inc - Dormant Projects 39

Immune Response BioPharma Inc - Locations And Subsidiaries 40

Head Office 40

Appendix 41

Methodology 41

Coverage 41

Secondary Research 41

Primary Research 41

Expert Panel Validation 41

Contact Us 41

Disclaimer 42

List of Tables

List of Tables

Immune Response BioPharma Inc, Key Facts 6

Immune Response BioPharma Inc - Pipeline by Indication, 2016 8

Immune Response BioPharma Inc - ...

List of Tables

Immune Response BioPharma Inc, Key Facts 6

Immune Response BioPharma Inc - Pipeline by Indication, 2016 8

Immune Response BioPharma Inc - Pipeline by Stage of Development, 2016 9

Immune Response BioPharma Inc - Monotherapy Products in Pipeline, 2016 10

Immune Response BioPharma Inc - Pre-Registration, 2016 11

Immune Response BioPharma Inc - Phase II, 2016 12

Immune Response BioPharma Inc - Phase I, 2016 13

Immune Response BioPharma Inc - Preclinical, 2016 14

Immune Response BioPharma Inc - Pipeline by Target, 2016 36

Immune Response BioPharma Inc - Pipeline by Route of Administration, 2016 37

Immune Response BioPharma Inc - Pipeline by Molecule Type, 2016 38

Immune Response BioPharma Inc - Dormant Developmental Projects,2016 39

List of Figures

List of Figures

Immune Response BioPharma Inc - Pipeline by Top 10 Indication, 2016 8

Immune Response BioPharma Inc - Pipeline by Stage of Development, ...

List of Figures

Immune Response BioPharma Inc - Pipeline by Top 10 Indication, 2016 8

Immune Response BioPharma Inc - Pipeline by Stage of Development, 2016 9

Immune Response BioPharma Inc - Monotherapy Products in Pipeline, 2016 10

Immune Response BioPharma Inc - Pipeline by Route of Administration, 2016 37

Immune Response BioPharma Inc - Pipeline by Molecule Type, 2016 38

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports